Glioblastoma is an aggressive and deadly form of brain cancer."
“胶质母细胞瘤是一种侵袭性强且致命的脑癌。”
She was diagnosed with
glioblastoma last month.
中文翻译为：“她上个月被诊断出患有胶质母细胞瘤。”
The patient underwent surgery to remove the
glioblastoma tumor.
这句话表示：“患者接受了手术以移除胶质母细胞瘤肿瘤。”
Advanced treatments for
glioblastoma are currently being researched.
意思是：“目前正在进行高级胶质母细胞瘤治疗的研究。”
He fought bravely against
glioblastoma but unfortunately passed away.
翻译成中文就是：“他勇敢地与胶质母细胞瘤抗争，但不幸去世了。”
Chemotherapy and radiation therapy are common treatments for
glioblastoma.
这句话说明：“化疗和放疗是胶质母细胞瘤常见的治疗方法。”
Glioblastomas account for about 15% of all brain tumors.
意味着：“胶质母细胞瘤约占所有脑瘤的15%。”
The prognosis for
glioblastoma patients is generally poor, with a median survival rate of around 15 months.
可以翻译为：“胶质母细胞瘤患者的预后通常较差，中位生存期约为15个月。”
Early detection and treatment can improve the chances of survival in
glioblastoma cases.
这句话意思是：“在胶质母细胞瘤病例中，早期检测和治疗可以提高存活率。”
The
glioblastoma had spread to other parts of her brain before it was detected.
中文解释为：“在被发现之前，胶质母细胞瘤已经扩散到她的大脑其他部位。”
Thanks to joint efforts by Chinese pharmaceutical companies and medical professionals, Chinese patients suffering from glioblastoma multiforme, the most aggressive cancer that begins within the brain, are likely to have more options for treatment, a key medical expert said.
Li Wenbin, deputy chief of the glioblastoma multiforme branch of the China Anti-Aancer Association, said Optune, a cancer therapy that uses electric fields tuned to specific frequencies to disrupt cell division, inhibiting tumor growth and causing affected cancer cells to die, will probably be approved for commercialization in the Chinese mainland within the year, marking a milestone of progress for the disease care.
Statistically, about five to eight people out of 100,000 will get glioma every year, with about half of them diagnosed with glioblastoma multiforme, which has a five-year survival rate of less than 5 percent, Li said, adding that the median survival time for patients is only about 14.6 months.
Li made the remarks at a media interview during a forum held recently in Beijing on new technologies for treating glioblastoma multiforme.
While Optune is not yet approved for commercialization in China, the technology was included and recommended as a treatment for glioblastoma multiforme in China's Glioma Treatment Guideline published in 2016.
In December 2018, the national treatment guideline was expanded to include both newly diagnosed and recurrent glioblastoma multiforme patients.
未经许可，严禁转发。QQ交流群：688169419